Taina Turpeenniemi-Hujanen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Taina Turpeenniemi-Hujanen has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Anne Talvensaari-Mattila
Department of Obstetrics and Gynecology, Oulu University Hospital, Oulu, Finland
1 shared publication - Ilkka Y. Järvelä
Department of Obstetrics and Gynecology, Oulu University Hospital, Oulu, Finland
1 shared publication - Kirsi Honkalampi
Philosophical Faculty, School of Educational Sciences and Psychology University of Eastern Finland Joensuu Finland
1 shared publication - Maarit Niinimäki
Department of Obstetrics and Gynecology Oulu University Hospital, Wellbeing Services County of North Ostrobothnia Oulu Finland
1 shared publication - Markku Ojanen
Faculty of Social Sciences: Welfare Sciences, Psychology, University of Tampere, Tampere, Finland
1 shared publication - Mira Kohonen
School of Educational Sciences and Psychology, University of Eastern Finland (UEF), Joensuu, Finland
1 shared publication
Latest Publications
- Open Access
- 25 June 2024
- Published by Springer Nature in International Journal of Behavioral Medicine
- Vol. 32 (3) , 325-340
Cancer Patients’ Social Relationships During 3 Years After Diagnosis—Generic and Cancer-Specific Social Networks
Background: Social relationships are important health resources and may be investigated as social networks. We measured cancer patients’ social subnetworks divided into generic social networks (people known to the patients) and disease-specific social networks (the persons talked to about the cancer) during 3 years after diagnosis. Method: Newly diagnosed patients with localized breast cancer (n = 222), lymphoma (n = 102), and prostate cancer (n = 141) completed a questionnaire on their social subnetworks at 2–5 months after diagnosis and 9, 18, and 36 months thereafter. Generic and cancer-specific numbers of persons of spouse/partner; other family; close relatives, in detail; and friends were recorded as well as cancer-specific numbers of persons in acquaintances; others with cancer; work community; healthcare professionals; and religious, hobby, and civic participation. The data was analyzed with regression models. Results: At study entry, most patients had a spouse/partner, all had close relatives (the younger, more often parents; and the older, more often adult children with families) and most also friends. The cancer was typically discussed with them, and often with acquaintances and other patients (74–86%). Only minor usually decreasing time trends were seen. However, the numbers of distant relatives and friends were found to strongly increase by the 9-month evaluation (P < 0.001). Conclusion: Cancer patients have multiple social relationships and usually talk to them about their cancer soon after diagnosis. Most temporal changes are due to the natural course of life cycle. The cancer widened the patients’ social networks by including other patients and healthcare professionals and by an increased number of relatives and friends.
- 25 June 2024
- Published by Springer Nature in International Journal of Behavioral Medicine
- Vol. 32 (3) , 325-340
Open AccessCancer Patients’ Social Relationships During 3 Years After Diagnosis—Generic and Cancer-Specific Social Networks
Background: Social relationships are important health resources and may be investigated as social networks. We measured cancer patients’ social subnetworks divided into generic social networks (people known to the patients) and disease-specific social networks (the persons talked to about the cancer) during 3 years after diagnosis. Method: Newly diagnosed patients with localized breast cancer (n = 222), lymphoma (n = 102), and prostate cancer (n = 141) completed a questionnaire on their social subnetworks at 2–5 months after diagnosis and 9, 18, and 36 months thereafter. Generic and cancer-specific numbers of persons of spouse/partner; other family; close relatives, in detail; and friends were recorded as well as cancer-specific numbers of persons in acquaintances; others with cancer; work community; healthcare professionals; and religious, hobby, and civic participation. The data was analyzed with regression models. Results: At study entry, most patients had a spouse/partner, all had close relatives (the younger, more often parents; and the older, more often adult children with families) and most also friends. The cancer was typically discussed with them, and often with acquaintances and other patients (74–86%). Only minor usually decreasing time trends were seen. However, the numbers of distant relatives and friends were found to strongly increase by the 9-month evaluation (P < 0.001). Conclusion: Cancer patients have multiple social relationships and usually talk to them about their cancer soon after diagnosis. Most temporal changes are due to the natural course of life cycle. The cancer widened the patients’ social networks by including other patients and healthcare professionals and by an increased number of relatives and friends.
- Open Access
- 1 January 2013
- Published by Springer Nature in Reproductive Biology and Endocrinology
- Vol. 11 (1) , 2
Circulating matrix metalloproteinase MMP-9 and MMP-2/TIMP-2 complex are associated with spontaneous early pregnancy failure
Trophoblast cell (CTB) invasion into the maternal endometrium plays a crucial role during human embryo implantation and placentation. This invasion is facilitated by the activity of matrix metalloproteinases, which are regulated by tissue inhibitors of MMPs (TIMPs).
- 1 January 2013
- Published by Springer Nature in Reproductive Biology and Endocrinology
- Vol. 11 (1) , 2
Open AccessCirculating matrix metalloproteinase MMP-9 and MMP-2/TIMP-2 complex are associated with spontaneous early pregnancy failure
Trophoblast cell (CTB) invasion into the maternal endometrium plays a crucial role during human embryo implantation and placentation. This invasion is facilitated by the activity of matrix metalloproteinases, which are regulated by tissue inhibitors of MMPs (TIMPs).